cagrilintide tirzepatide blend and Cagrilintide, Tirzepatide, and Retatrutide Peptides: Comparing Metabolic Mechanisms Cagrilintide + GLP-1 T (1+10mg)

Its extended activity allows for longer biological exposure compared to natural IGF-1, which has led to interest in research and clinical settings

Saxenda Lawsuit Overview People are filing Saxenda lawsuits after experiencing a range of severe side effects, including stomach and bowel injuries, vision loss, and blood clots

Second cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk

Manufacturer Direct-to-Patient (Cash-Pay) Programs Both Novo Nordisk and Eli Lilly have launched direct-to-patient platforms offering GLP-1 medications at flat cash-pay rates significantly below the insurance list price

Phase1 clinical trial of high doses of Seleno-L-methionine (SLM), in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients